# Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer

> **NCT03719495** · — · COMPLETED · sponsor: **Duke University** · enrollment: 68 (actual)

## Conditions studied

- Breast Cancer
- Estrogen Receptor-positive Breast Cancer
- Healthy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03719495
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-19
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2024-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03719495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03719495, "Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03719495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*